Yang Ning
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yang Ning has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Cheng Xu
Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, China
3 shared publicationsYu Du
Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China
3 shared publicationsAndrew Liaw
The University of Queensland
2 shared publicationsChang Liu
Department of Periodontology, Hospital of Stomatology, Sun Yat‐sen University, Guangdong Province Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat‐sen University, Guangzhou, Guangdong, China
2 shared publications- Chun Liu
Centre for Orofacial Regeneration, Rehabilitation and Reconstruction (COR3), Epigenetics Nanodiagnostic and Therapeutic Group, School of Dentistry The University of Queensland Brisbane Queensland Australia
2 shared publications Jenny Wang
The University of Queensland
2 shared publications
Latest Publications
- 3 September 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (36) , 48718-48733
Salivary Extracellular Vesicles from Host, Bacteria and Fungus as Nanomessengers Reflecting Host−Microbiome Interaction in Periodontal Inflammation
Extracellular vesicles (EVs) secreted by the host and polymicrobial oral community are natural endogenous biological nanoparticles that mediate host−microbe interactions. Given their abundance in biofluids, host, fungal and bacterial EVs circulating in saliva may reflect periodontitis-associated microbial dysbiosis and inflammation. In this study, salivary EVs from 20 healthy controls and 57 stages III/IV periodontitis were isolated using a dual strategy: immunoaffinity to isolate host EVs for cytokine profiling, followed by size-exclusion chromatography (SEC) to enrich non-host (microbial) EVs for 16S rRNA and fungal ITS sequencing. In periodontitis, we observed a significant increase in CD49e+ and CD105+ host EV subpopulations and elevated host EV-associated cytokines of tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor (GM-CSF), indicating an enhanced inflammatory host-EV profile. 16s rRNA sequencing of non-host microbial EV-DNA profiling revealed enrichment of bacterial EVs (BEVs), including genera Porphyromonas, Treponema, Filifactor, and Tannerella, with species of Porphyromonas gingivalis, Filifactor alocis, Tannerella forsythia, Treponema denticola, and Treponema socranskii. In contrast, commensal genera BEVs (Neisseria, Haemophilus) and fungal EVs from Malassezia globosa were enriched in health. Fungal EVs from Candida albicans and M. arunalokeiwere also elevated in disease. Combined host-EVs-IL-9 and T. forsythia-BEVs achieved an AUC of 0.989, increasing to 0.992 with the addition of F. alocis-BEVs, outperforming individual markers (AUC = 0.85−0.91). Pooled periodontitis microbial EVs (10 µg/mL) induced a proinflammatory response in the oral keratinocytes (OKFs) after 24 h, with increased IL-6 and IL-8 cytokines, and upregulated mRNA expression of C-C motif chemokine ligand 2 (CCL2), IL-1β, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) compared with the no-EV control. Our findings demonstrated that salivary host-, bacterial-, and fungal-derived salivary EVs act as natural nanomessengers reflecting host−microbiome interactions and represent promising non-invasive candidate biomarkers of periodontitis.
- 3 September 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (36) , 48718-48733
Salivary Extracellular Vesicles from Host, Bacteria and Fungus as Nanomessengers Reflecting Host−Microbiome Interaction in Periodontal Inflammation
Extracellular vesicles (EVs) secreted by the host and polymicrobial oral community are natural endogenous biological nanoparticles that mediate host−microbe interactions. Given their abundance in biofluids, host, fungal and bacterial EVs circulating in saliva may reflect periodontitis-associated microbial dysbiosis and inflammation. In this study, salivary EVs from 20 healthy controls and 57 stages III/IV periodontitis were isolated using a dual strategy: immunoaffinity to isolate host EVs for cytokine profiling, followed by size-exclusion chromatography (SEC) to enrich non-host (microbial) EVs for 16S rRNA and fungal ITS sequencing. In periodontitis, we observed a significant increase in CD49e+ and CD105+ host EV subpopulations and elevated host EV-associated cytokines of tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor (GM-CSF), indicating an enhanced inflammatory host-EV profile. 16s rRNA sequencing of non-host microbial EV-DNA profiling revealed enrichment of bacterial EVs (BEVs), including genera Porphyromonas, Treponema, Filifactor, and Tannerella, with species of Porphyromonas gingivalis, Filifactor alocis, Tannerella forsythia, Treponema denticola, and Treponema socranskii. In contrast, commensal genera BEVs (Neisseria, Haemophilus) and fungal EVs from Malassezia globosa were enriched in health. Fungal EVs from Candida albicans and M. arunalokeiwere also elevated in disease. Combined host-EVs-IL-9 and T. forsythia-BEVs achieved an AUC of 0.989, increasing to 0.992 with the addition of F. alocis-BEVs, outperforming individual markers (AUC = 0.85−0.91). Pooled periodontitis microbial EVs (10 µg/mL) induced a proinflammatory response in the oral keratinocytes (OKFs) after 24 h, with increased IL-6 and IL-8 cytokines, and upregulated mRNA expression of C-C motif chemokine ligand 2 (CCL2), IL-1β, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) compared with the no-EV control. Our findings demonstrated that salivary host-, bacterial-, and fungal-derived salivary EVs act as natural nanomessengers reflecting host−microbiome interactions and represent promising non-invasive candidate biomarkers of periodontitis.
- Open Access
- 21 October 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1-10
A rare case of peripheral ameloblastic fibroma manifesting as a maxillary gingival mass
Ameloblastic fibroma (AF) is a rare benign odontogenic tumor characterized by the coexistence of epithelial and mesenchymal components, typically arising intraosseously in the posterior mandible during the first two decades of life. Its peripheral variant, occurring extraosseously in gingival soft tissue without bone involvement, is exceedingly rare. Owing to its clinical resemblance to reactive gingival lesions, peripheral AF poses diagnostic challenges and is frequently misdiagnosed without histopathological confirmation. We report a case of peripheral AF in a 34-year-old Chinese woman who presented with a slow-growing, asymptomatic soft tissue mass on the palatal gingiva between teeth 23 and 24. Clinical examination revealed a well-defined, sessile lesion measuring 6 mm × 6 mm, with no signs of pain, bleeding, or tooth mobility. Radiographic evaluation, including panoramic imaging and cone beam computed tomography, confirmed the absence of bone involvement. The lesion was excised under local anesthesia, followed by root planing and soft tissue reconstruction using a laterally positioned flap to preserve esthetics. Histopathological examination demonstrated classic features of AF, including epithelial strands and cords within a cell-rich ectomesenchymal stroma, with peripheral palisading and central stellate reticulum-like cells. Immunohistochemistry revealed low Ki-67 proliferation index and negative BRAF expression, supporting the benign nature of the lesion. The final diagnosis was peripheral ameloblastic fibroma. Follow-up over 20 months showed no recurrence and excellent gingival healing with preserved architecture. This case underscores the importance of considering peripheral AF in the differential diagnosis of gingival masses, particularly those mimicking reactive lesions. Histopathological and immunohistochemical analyses are essential for accurate diagnosis and appropriate management. Conservative surgical excision with careful flap design can achieve excellent functional and esthetic outcomes. Given its rarity, every well-documented case of peripheral AF contributes meaningfully to the understanding of its clinical behavior and optimal treatment strategies.
- 21 October 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1-10
Open AccessA rare case of peripheral ameloblastic fibroma manifesting as a maxillary gingival mass
Ameloblastic fibroma (AF) is a rare benign odontogenic tumor characterized by the coexistence of epithelial and mesenchymal components, typically arising intraosseously in the posterior mandible during the first two decades of life. Its peripheral variant, occurring extraosseously in gingival soft tissue without bone involvement, is exceedingly rare. Owing to its clinical resemblance to reactive gingival lesions, peripheral AF poses diagnostic challenges and is frequently misdiagnosed without histopathological confirmation. We report a case of peripheral AF in a 34-year-old Chinese woman who presented with a slow-growing, asymptomatic soft tissue mass on the palatal gingiva between teeth 23 and 24. Clinical examination revealed a well-defined, sessile lesion measuring 6 mm × 6 mm, with no signs of pain, bleeding, or tooth mobility. Radiographic evaluation, including panoramic imaging and cone beam computed tomography, confirmed the absence of bone involvement. The lesion was excised under local anesthesia, followed by root planing and soft tissue reconstruction using a laterally positioned flap to preserve esthetics. Histopathological examination demonstrated classic features of AF, including epithelial strands and cords within a cell-rich ectomesenchymal stroma, with peripheral palisading and central stellate reticulum-like cells. Immunohistochemistry revealed low Ki-67 proliferation index and negative BRAF expression, supporting the benign nature of the lesion. The final diagnosis was peripheral ameloblastic fibroma. Follow-up over 20 months showed no recurrence and excellent gingival healing with preserved architecture. This case underscores the importance of considering peripheral AF in the differential diagnosis of gingival masses, particularly those mimicking reactive lesions. Histopathological and immunohistochemical analyses are essential for accurate diagnosis and appropriate management. Conservative surgical excision with careful flap design can achieve excellent functional and esthetic outcomes. Given its rarity, every well-documented case of peripheral AF contributes meaningfully to the understanding of its clinical behavior and optimal treatment strategies.
- 29 September 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (41) , 13434-13445
Proteome and microbiome profiles of polymicrobial salivary biofilms on 3D MEW fibrous scaffolds: biomimetic ECM-inspired structures
Replicating the structural complexity of polymicrobial oral biofilms in vitro remains a significant challenge in biomaterials research. Nevertheless, developing clinically relevant biofilm models is crucial for advancing our understanding of biofilm–host interactions and elucidating how biomaterials influence microbial composition, behaviour, and overall biofilm dynamics. In this work, 3D biomimetic fibrous scaffolds made from medical-grade polycaprolactone (mPCL) were fabricated using the melt electrowriting (MEW) technique. The effects on biofilm viability, activity, microbiome, and proteome profiles were assessed on 3D fibrous scaffolds and conventional 2D tissue culture plates (TCP). Human saliva was cultured on MEW mPCL (3D BF) and TCP (2D BF) for 4 days, followed by microbiome profiling via 16S rRNA sequencing and proteomic analysis using LC–MS/MS, SWATH with GO and KEGG pathway enrichment. The results demonstrated that 3D MEW mPCL scaffolds enhanced biofilm biomass, thickness, and viability. Microbiome analysis revealed that 3D BF was enriched with both commensals and pathogens, including Veillonella, Peptostreptococcus, Porphyromonas gingivalis, and Treponema denticola, alongside probiotic species like Lactobacillus acidophilus. Pooled proteomic data from three technical repeats, along with GO and KEGG analyses, revealed a functionally dynamic biofilm ecosystem characterised by elevated expression of proteins involved in glycolysis, the TCA cycle, and nucleotide metabolism, highlighting pathways essential for biofilm survival, stress adaptation, and host interaction. These ‘proof-of-concept’ findings highlight the potential of 3D MEW fibrous mPCL scaffolds as a biomimetic 3D platform capable of accurately recapitulating the dynamic spatial and metabolic complexity of oral biofilms, thereby facilitating innovative investigations into microbial ecology, host–pathogen interactions, and the accelerated development of targeted antimicrobial therapies.
- 29 September 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (41) , 13434-13445
Proteome and microbiome profiles of polymicrobial salivary biofilms on 3D MEW fibrous scaffolds: biomimetic ECM-inspired structures
Replicating the structural complexity of polymicrobial oral biofilms in vitro remains a significant challenge in biomaterials research. Nevertheless, developing clinically relevant biofilm models is crucial for advancing our understanding of biofilm–host interactions and elucidating how biomaterials influence microbial composition, behaviour, and overall biofilm dynamics. In this work, 3D biomimetic fibrous scaffolds made from medical-grade polycaprolactone (mPCL) were fabricated using the melt electrowriting (MEW) technique. The effects on biofilm viability, activity, microbiome, and proteome profiles were assessed on 3D fibrous scaffolds and conventional 2D tissue culture plates (TCP). Human saliva was cultured on MEW mPCL (3D BF) and TCP (2D BF) for 4 days, followed by microbiome profiling via 16S rRNA sequencing and proteomic analysis using LC–MS/MS, SWATH with GO and KEGG pathway enrichment. The results demonstrated that 3D MEW mPCL scaffolds enhanced biofilm biomass, thickness, and viability. Microbiome analysis revealed that 3D BF was enriched with both commensals and pathogens, including Veillonella, Peptostreptococcus, Porphyromonas gingivalis, and Treponema denticola, alongside probiotic species like Lactobacillus acidophilus. Pooled proteomic data from three technical repeats, along with GO and KEGG analyses, revealed a functionally dynamic biofilm ecosystem characterised by elevated expression of proteins involved in glycolysis, the TCA cycle, and nucleotide metabolism, highlighting pathways essential for biofilm survival, stress adaptation, and host interaction. These ‘proof-of-concept’ findings highlight the potential of 3D MEW fibrous mPCL scaffolds as a biomimetic 3D platform capable of accurately recapitulating the dynamic spatial and metabolic complexity of oral biofilms, thereby facilitating innovative investigations into microbial ecology, host–pathogen interactions, and the accelerated development of targeted antimicrobial therapies.
- Open Access
- 1 September 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1666965
Mechanisms of fungal pathogenic DNA-activated STING pathway in biofilms and its implication in dental caries onset
Dental caries, a prevalent oral disease, has long been attributed primarily to bacteria, but emerging evidence highlights the critical role of fungi in its pathogenesis. Fungal biofilms, predominantly Candida albicans, release extracellular DNA (eDNA) and DNA-carrying extracellular vesicles (EVs). Together with bacterial eDNA, these form the biofilm matrix and can activate the host cGAS-STING signaling pathway. This review systematically elaborates on the molecular architecture and biological functions of the cGAS-STING pathway, comparing mechanistic differences in its activation by viral, bacterial, and fungal DNA. It further explores direct and indirect modes of STING pathway activation by fungal eDNA and EV-carried DNA, along with their immunoregulatory roles. Specifically, it discusses the interactive mechanisms between fungal biofilms and STING activation in root caries onset, emphasizing the dual effects of STING-mediated immune responses—enhancing antifungal immunity while potentially exacerbating tissue damage via excessive inflammation. Finally, this review outlines current knowledge gaps and future research directions, aiming to provide novel insights for precision prevention and treatment of dental caries.
- 1 September 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1666965
Open AccessMechanisms of fungal pathogenic DNA-activated STING pathway in biofilms and its implication in dental caries onset
Dental caries, a prevalent oral disease, has long been attributed primarily to bacteria, but emerging evidence highlights the critical role of fungi in its pathogenesis. Fungal biofilms, predominantly Candida albicans, release extracellular DNA (eDNA) and DNA-carrying extracellular vesicles (EVs). Together with bacterial eDNA, these form the biofilm matrix and can activate the host cGAS-STING signaling pathway. This review systematically elaborates on the molecular architecture and biological functions of the cGAS-STING pathway, comparing mechanistic differences in its activation by viral, bacterial, and fungal DNA. It further explores direct and indirect modes of STING pathway activation by fungal eDNA and EV-carried DNA, along with their immunoregulatory roles. Specifically, it discusses the interactive mechanisms between fungal biofilms and STING activation in root caries onset, emphasizing the dual effects of STING-mediated immune responses—enhancing antifungal immunity while potentially exacerbating tissue damage via excessive inflammation. Finally, this review outlines current knowledge gaps and future research directions, aiming to provide novel insights for precision prevention and treatment of dental caries.
- 23 August 2025
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 169, 103247
TIPs: Tooth instance and pulp segmentation based on hierarchical extraction and fusion of anatomical priors from cone-beam CT
- 23 August 2025
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 169, 103247
TIPs: Tooth instance and pulp segmentation based on hierarchical extraction and fusion of anatomical priors from cone-beam CT
- 21 March 2025
- Published by Springer Nature
- Vol. 1472, 245-260
Periodontal Treatment to Improve General Health and Manage Systemic Diseases
Periodontitis is increasingly recognized for its role in overall health and its associations with systemic conditions. Shared etiological factors, including microbiological, immunological, genetic, and environmental influences, have prompted interest in the potential impact of periodontal therapy on broader health outcomes. The oral microbiome plays a key role in the pathogenesis of periodontitis, with microbial imbalances (dysbiosis) contributing to inflammation and systemic disease progression. Additionally, immune responses to periodontal infection, such as chronic inflammation and dysregulated immune activity, are central to linking periodontitis with conditions like diabetes, cardiovascular disease, and autoimmune disorders. This chapter explores the connections between periodontal treatment and systemic diseases, such as diabetes, rheumatoid arthritis, cardiovascular disease, chronic kidney disease, Alzheimer’s disease, digestive disorders, and respiratory disease. It also reviews the current research on the mechanisms, including microbial and immune factors, that underlie these associations. By emphasizing the role of periodontal health, the oral microbiome, and immune regulation in disease prevention and management, this chapter underscores the importance of integrated healthcare approaches to improve patient outcomes.
- 21 March 2025
- Published by Springer Nature
- Vol. 1472, 245-260
Periodontal Treatment to Improve General Health and Manage Systemic Diseases
Periodontitis is increasingly recognized for its role in overall health and its associations with systemic conditions. Shared etiological factors, including microbiological, immunological, genetic, and environmental influences, have prompted interest in the potential impact of periodontal therapy on broader health outcomes. The oral microbiome plays a key role in the pathogenesis of periodontitis, with microbial imbalances (dysbiosis) contributing to inflammation and systemic disease progression. Additionally, immune responses to periodontal infection, such as chronic inflammation and dysregulated immune activity, are central to linking periodontitis with conditions like diabetes, cardiovascular disease, and autoimmune disorders. This chapter explores the connections between periodontal treatment and systemic diseases, such as diabetes, rheumatoid arthritis, cardiovascular disease, chronic kidney disease, Alzheimer’s disease, digestive disorders, and respiratory disease. It also reviews the current research on the mechanisms, including microbial and immune factors, that underlie these associations. By emphasizing the role of periodontal health, the oral microbiome, and immune regulation in disease prevention and management, this chapter underscores the importance of integrated healthcare approaches to improve patient outcomes.
- 5 February 2022
- Published by Taylor & Francis in Connective Tissue Research
- Vol. 63 (5) , 485-497
Pigment epithelium-derived factor modulates periodontal homeostasis in mice and induces osteogenic differentiation of human periodontal ligament fibroblasts
The aim of this study was to investigate the influence of pigment epithelium-derived factor (PEDF) on periodontal homeostasis in mice and the osteogenic differentiation of human periodontal ligamen...
- 5 February 2022
- Published by Taylor & Francis in Connective Tissue Research
- Vol. 63 (5) , 485-497
Pigment epithelium-derived factor modulates periodontal homeostasis in mice and induces osteogenic differentiation of human periodontal ligament fibroblasts
The aim of this study was to investigate the influence of pigment epithelium-derived factor (PEDF) on periodontal homeostasis in mice and the osteogenic differentiation of human periodontal ligamen...
- Open Access
- 7 July 2021
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 368 (14)
Role of agglutinin-like sequence protein 3 (Als3) in the structure and antifungal resistance of Candida albicans biofilms
Agglutinin-like sequence protein 3 (Als3) is a cell surface glycoprotein of Candida albicans that plays essential roles in the processes of adherence and biofilm formation in vitro. In this study, we focused on the contribution of Als3 to the structure and drug susceptibility of biofilms. The C. albicans wild-type (WT) strain DAY185, the als3Δ/Δ null strain and the als3Δ/Δ + pALS3 complemented strain were used. Colony-forming unit enumeration, crystal violet and cell surface hydrophobicity assays, scanning electron microscopy and confocal laser scanning microscopy coupled with analyses using COMSTAT software were performed to evaluate the biomass and architecture of the biofilms. The detailed architectural analysis showed a significant variation in the biofilm parameters of the als3Δ/Δ biofilms compared with those of the WT biofilms. Fluconazole, miconazole and amphotericin B were selected as the antifungal agents for the antimycotic susceptibility test, and increased susceptibility was found with the ALS3 deletion biofilms. A quantitative real-time polymerase chain reaction analysis showed downregulation of biofilm formation-related genes (ALS1, EFG1, HWP1 and CSH1) and drug resistance-related genes (ERG11, CDR1, CDR2 and MDR1) in the als3Δ/Δ biofilms. We concluded that Als3 contributes to biofilm formation by changing the biofilm architecture and is involved in the antifungal resistance of C. albicans biofilms.
- 7 July 2021
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 368 (14)
Open AccessRole of agglutinin-like sequence protein 3 (Als3) in the structure and antifungal resistance of Candida albicans biofilms
Agglutinin-like sequence protein 3 (Als3) is a cell surface glycoprotein of Candida albicans that plays essential roles in the processes of adherence and biofilm formation in vitro. In this study, we focused on the contribution of Als3 to the structure and drug susceptibility of biofilms. The C. albicans wild-type (WT) strain DAY185, the als3Δ/Δ null strain and the als3Δ/Δ + pALS3 complemented strain were used. Colony-forming unit enumeration, crystal violet and cell surface hydrophobicity assays, scanning electron microscopy and confocal laser scanning microscopy coupled with analyses using COMSTAT software were performed to evaluate the biomass and architecture of the biofilms. The detailed architectural analysis showed a significant variation in the biofilm parameters of the als3Δ/Δ biofilms compared with those of the WT biofilms. Fluconazole, miconazole and amphotericin B were selected as the antifungal agents for the antimycotic susceptibility test, and increased susceptibility was found with the ALS3 deletion biofilms. A quantitative real-time polymerase chain reaction analysis showed downregulation of biofilm formation-related genes (ALS1, EFG1, HWP1 and CSH1) and drug resistance-related genes (ERG11, CDR1, CDR2 and MDR1) in the als3Δ/Δ biofilms. We concluded that Als3 contributes to biofilm formation by changing the biofilm architecture and is involved in the antifungal resistance of C. albicans biofilms.
- Open Access
- 1 May 2020
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 8 (5) , e2830
Autologous Fat Transfer for Scar Prevention and Remodeling: A Randomized, Blinded, Placebo-controlled Trial
Background: Autologous fat transfer—also referred to as fat grafting—has been reported to provide beneficial effects to overlying scar and skin. Despite procedural frequency, there is a paucity of high-level evidence guiding the surgeon in technique, patient selection, and efficacy. Methods: A multicenter, double-blinded, randomized, internally placebo-controlled trial was performed with an aim to qualitatively and quantitatively evaluate the impact of autologous fat transfer on the quality of overlying scar tissue. Fat-grafted scars were evaluated and compared with paired, saline-injected “control” scars. Subjective and objective metrics were evaluated in treated sites for 12 months after treatment. Results: Blinded qualitative results demonstrated a statistically significant improvement in scar quality over time in fat-grafted scars. However, these improvements were not found to be statistically different from changes noted in scars treated with saline. In addition, objective metrics did not statistically differ between saline-injected and autologous fat-grafted scars. Conclusions: Our results demonstrate that autologous fat grafting can improve the qualitative profile of a scar from both the patient and observer perspectives. However, there was no difference in improvement when compared with scars that were treated with saline in a randomized and blinded fashion. These results demonstrate that any improvements in scar quality related to fat grafting are also achieved using saline and suggest that mechanisms other than cell activity may be at play. Additional randomized, blinded, placebo-controlled trials are required to either corroborate or contest the putative beneficial effect(s) of adipose tissue on scar remodeling.
- 1 May 2020
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 8 (5) , e2830
Open AccessAutologous Fat Transfer for Scar Prevention and Remodeling: A Randomized, Blinded, Placebo-controlled Trial
Background: Autologous fat transfer—also referred to as fat grafting—has been reported to provide beneficial effects to overlying scar and skin. Despite procedural frequency, there is a paucity of high-level evidence guiding the surgeon in technique, patient selection, and efficacy. Methods: A multicenter, double-blinded, randomized, internally placebo-controlled trial was performed with an aim to qualitatively and quantitatively evaluate the impact of autologous fat transfer on the quality of overlying scar tissue. Fat-grafted scars were evaluated and compared with paired, saline-injected “control” scars. Subjective and objective metrics were evaluated in treated sites for 12 months after treatment. Results: Blinded qualitative results demonstrated a statistically significant improvement in scar quality over time in fat-grafted scars. However, these improvements were not found to be statistically different from changes noted in scars treated with saline. In addition, objective metrics did not statistically differ between saline-injected and autologous fat-grafted scars. Conclusions: Our results demonstrate that autologous fat grafting can improve the qualitative profile of a scar from both the patient and observer perspectives. However, there was no difference in improvement when compared with scars that were treated with saline in a randomized and blinded fashion. These results demonstrate that any improvements in scar quality related to fat grafting are also achieved using saline and suggest that mechanisms other than cell activity may be at play. Additional randomized, blinded, placebo-controlled trials are required to either corroborate or contest the putative beneficial effect(s) of adipose tissue on scar remodeling.